Seeking Alpha

jamaicanholiday

jamaicanholiday
Send Message
View as an RSS Feed
View jamaicanholiday's Comments BY TICKER:
Latest  |  Highest rated
  • Novavax raises gross proceeds of $115M [View news story]
    Say it!
    Jun 11 05:15 PM | Likes Like |Link to Comment
  • Novavax: A Unique Opportunity [View article]
    Insightful, well constructed information! I am in full agreement, and investing in Novavax. The share price is being held down some by representatives of Big Pharma, as they have some interest in acquiring parts or all of Novavax. That said, the data are very compelling and with the financing described above, Novavax can take 1-2 of these candidates into Phase III trials. The VLP technology, along with specific products for pandemic, seasonal and RSV.......the data is really solid!
    May 15 04:27 PM | 2 Likes Like |Link to Comment
  • Inovio Neglected The Sign: Don't Feed The Bears! [View article]
    I invest in NVAX as well as INO. NVAX has had dilution in the past too. About 6 months ago, announced a share sale. price dropped about 10% on the announcement but recoverd and then drove strongly higher when the shares were sold. So, consider any dip on a shelp registration a reason to buy. When they actually generate the cash, shares will recover.
    Feb 2 10:06 AM | 1 Like Like |Link to Comment
  • Spot Tenbagger Discovery Potential In Biotech: Michael Berry [View article]
    Tell me........what is your view on Novavax? NVAX.

    Check them out; company is making great clinical progress, making acquisition, getting non-dilutative funding. Current price $2.90. Lazard projects $11 / share. Meets your criteria for a large gainer!
    Aug 25 10:22 AM | Likes Like |Link to Comment
  • Inovio Pharmaceuticals soars on no specific news driver today [View news story]
    made money on it today........happy.
    Aug 21 06:12 PM | Likes Like |Link to Comment
  • Lazard hikes Novavax's PT; shares soar [View news story]
    my guess is that BARDA is consulting with the FDA regarding recent trial results for possible "fast track" on one of their vaccines. Also, on the call yesterday, CEO Stan Erck referenced for the first time, the potential for "licensing agreements".......
    Aug 15 08:54 AM | Likes Like |Link to Comment
  • Lazard hikes Novavax's PT; shares soar [View news story]
    Interesting news today and well deserved attention! This could set a new floor for the stock and certainly a 52 week high today.
    Aug 15 08:14 AM | Likes Like |Link to Comment
  • The Explosive Biotech Calendar Catalyst Play: Novavax's 1st Analyst Day [View article]
    Nicely done.........certainly intriguing, the current situation with Novavax (NVAX). Been long in NVAX for sometime now; seems like things are lining up nicely. BTW, the loss and revenue reductions were expected. NVAX is still clinical stage and revenue / profits are not so material as cash burn rate and cash on hand. Expect an announcement BEFORE Sept. 24th, that BARDA and NVAX have a NEW contract, which puts to rest any concerns in the near term about funding the trials and product development for flu. As for RSV, PATH and Bill Gates continue to have tons of cash to invest and I suspect continuation of that partnership as well, in the near term. NET - lots of positive catalysts for NVAX in the near term.
    Aug 13 08:14 PM | 2 Likes Like |Link to Comment
  • Novavax Management Discusses Q2 2013 Results - Earnings Call Transcript [View article]
    Management self inflicted wound today by not getting the BARDA renewal done BEFORE the earnings call. The BARDA contract will be renewed. Little doubt about that, given the outstanding data. For some reason, it is taking longer than expected. That unknown is creating risk and why we had the sell off. AS SOON AS BARDA CONTRACT IS RENEWED, SHARE PRICE WILL REBOUND SHARPLY.
    Aug 8 08:36 PM | 1 Like Like |Link to Comment
  • More on Novavax Q2: shares tumble [View news story]
    earnings for clinical biotechs are meaningless.........it is about pipeline progress and outcomes. share sell off is BUYING opportunity. nobody with any basic insight expected NVAX to report earnings. irrational reaction to news today. BUY on dips.
    Aug 8 10:45 AM | 1 Like Like |Link to Comment
  • Novavax (NVAX) appoints Barclay Phillips Senior Vice President and CFO effective today. Phillips formerly served as CFO of Micromet, which was acquired by Amgen last year. CEO Stanley Erck calls Phillips "a well-known and talented executive." (PR[View news story]
    GREAT HIRE - well connected on both Finance AND Pharma sides of the equation. Progressive thinker. Motivated. Ethical.

    Huge win for NVAX.
    Jun 24 04:55 PM | Likes Like |Link to Comment
  • Will Influenza A H7N9 Generate Opportunities For Pharma? [View article]
    Yes, very interested to better understand what you can discover about Novavax (NVAX) in this area. They use VLP technology (vs egg based) and claim they can turnaround vaccines much more quickly with this technology. If true, they could be a strong candidate for any pandemic responses.
    May 21 01:45 PM | 1 Like Like |Link to Comment
  • Jamba Squeezing Up A Turnaround [View article]
    management takes too much compensation, for too little results. shareholders are frustrated.
    May 1 05:58 PM | Likes Like |Link to Comment
  • Shares of Jamba (JMBA) fall 16.2% premarket in thin trading. Last week's Q4 report from the company was a mixed bag with gains at franchises offsetting a sales slip at company-owned stores. [View news story]
    this is a computer generated, Seeking Alpha message. Has no merit. Do not over react. Nothing to be concerned about.
    Mar 11 09:10 AM | Likes Like |Link to Comment
  • Novavax (NVAX): Q4 EPS of -$0.06 misses by $0.01. Revenue of $4.56M misses by $2.48M. (PR[View news story]
    Clinical Stage BioPharma............e... are irrelevant. Pipeline & Cash are most important. Great advancements on both fronts. Share price will climb. Company positioning itself for future success. Buy in dips.
    Mar 1 08:37 AM | 1 Like Like |Link to Comment
COMMENTS STATS
38 Comments
25 Likes